Antigen design enhances the immunogenicity of Semliki Forest virus-based therapeutic human papillomavirus vaccines.
about
Perspectives for therapeutic HPV vaccine developmentEpitope Prediction Assays Combined with Validation Assays Strongly Narrows down Putative Cytotoxic T Lymphocyte EpitopesCurrent state in the development of candidate therapeutic HPV vaccinesThe current state of therapeutic and T cell-based vaccines against human papillomaviruses.Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens
P2860
Antigen design enhances the immunogenicity of Semliki Forest virus-based therapeutic human papillomavirus vaccines.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Antigen design enhances the im ...... human papillomavirus vaccines.
@en
Antigen design enhances the im ...... human papillomavirus vaccines.
@nl
type
label
Antigen design enhances the im ...... human papillomavirus vaccines.
@en
Antigen design enhances the im ...... human papillomavirus vaccines.
@nl
prefLabel
Antigen design enhances the im ...... human papillomavirus vaccines.
@en
Antigen design enhances the im ...... human papillomavirus vaccines.
@nl
P2093
P2860
P356
P1433
P1476
Antigen design enhances the im ...... human papillomavirus vaccines
@en
P2093
H W Nijman
J B Haanen
K Oosterhuis
P2860
P2888
P304
P356
10.1038/GT.2015.24
P577
2015-03-26T00:00:00Z
P6179
1021831530